1. Home
  2. TEVA vs BAP Comparison

TEVA vs BAP Comparison

Compare TEVA & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • BAP
  • Stock Information
  • Founded
  • TEVA 1901
  • BAP 1889
  • Country
  • TEVA Israel
  • BAP Peru
  • Employees
  • TEVA N/A
  • BAP N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • BAP Major Banks
  • Sector
  • TEVA Health Care
  • BAP Finance
  • Exchange
  • TEVA Nasdaq
  • BAP Nasdaq
  • Market Cap
  • TEVA 21.2B
  • BAP 21.1B
  • IPO Year
  • TEVA N/A
  • BAP 1995
  • Fundamental
  • Price
  • TEVA $18.39
  • BAP $278.50
  • Analyst Decision
  • TEVA Strong Buy
  • BAP Buy
  • Analyst Count
  • TEVA 7
  • BAP 6
  • Target Price
  • TEVA $24.71
  • BAP $245.00
  • AVG Volume (30 Days)
  • TEVA 10.3M
  • BAP 368.6K
  • Earning Date
  • TEVA 11-05-2025
  • BAP 11-06-2025
  • Dividend Yield
  • TEVA N/A
  • BAP 3.96%
  • EPS Growth
  • TEVA N/A
  • BAP 26.90
  • EPS
  • TEVA N/A
  • BAP 22.19
  • Revenue
  • TEVA $16,628,000,000.00
  • BAP $5,576,317,301.00
  • Revenue This Year
  • TEVA $4.07
  • BAP $24.04
  • Revenue Next Year
  • TEVA $0.81
  • BAP $6.23
  • P/E Ratio
  • TEVA N/A
  • BAP $12.20
  • Revenue Growth
  • TEVA 2.08
  • BAP 20.05
  • 52 Week Low
  • TEVA $12.47
  • BAP $165.51
  • 52 Week High
  • TEVA $22.80
  • BAP $280.88
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 49.75
  • BAP 83.75
  • Support Level
  • TEVA $18.46
  • BAP $264.25
  • Resistance Level
  • TEVA $19.98
  • BAP $268.49
  • Average True Range (ATR)
  • TEVA 0.50
  • BAP 5.12
  • MACD
  • TEVA -0.10
  • BAP 0.75
  • Stochastic Oscillator
  • TEVA 23.68
  • BAP 91.85

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About BAP Credicorp Ltd.

Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.

Share on Social Networks: